Combination treatment in autoimmune diseases: systemic lupus erythematosusMORONI, G; DELLA CASA ALBERIGHI, O; PONTICELLI, C et al.Springer seminars in immunopathology. 2001, Vol 23, Num 1-2, pp 75-89, issn 0344-4325Article

Physiologically Based Pharmacokinetic (PBPK) Modeling in ChildrenBARRETT, J. S; DELLA CASA ALBERIGHI, O; LÄER, S et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 1, pp 40-49, issn 0009-9236, 10 p.Article

Statistical considerations concerning clinical studies designed to assess DC-ARTsDELLA CASA-ALBERIGHI, O; FERRARA, R; MARUBINI, E et al.Clinical and experimental rheumatology (Testo stampato). 1997, Vol 15, pp S45-S52, issn 0392-856X, SUP17Article

Radiographic changes in the feet of patients with early rheumatoid arthritisPRIOLO, F; BACARINI, L; CAMMISA, M et al.Journal of rheumatology. 1997, Vol 24, Num 11, pp 2113-2118, issn 0315-162XArticle

Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosusDAMMACCO, F; DELLA CASA ALBERIGHI, O; FERRACCIOLI, G et al.International journal of clinical & laboratory research. 2000, Vol 30, Num 2, pp 67-73, issn 0940-5437Article

Lymphocyte abnormalities in patients with macro- and micro-prolactinoma : different effects of bromocriptine treatment in the two groupsDE BERNARDI, B; SCORZA, R; HU, C et al.International journal of neuroscience. 1990, Vol 51, Num 3-4, pp 261-263, issn 0020-7454, 3 p.Conference Paper

NK cells in patients with peripheral neuropathy and IgM monoclonal protein reacting with the myelin-associated glycoprotein (MAG)DELLA CASA ALBERIGHI, O; ORAZIO, E. N; BONARA, P et al.Journal of neuroimmunology. 1988, Vol 18, Num 3, pp 207-216, issn 0165-5728Article

Open noncontrolled multicenter long-term trial with cisloporin in endogenous non-infectious uveitisSECCHI, A. G; DE ROSA, C; ZENONI, S et al.Ophthalmologica (Basel). 1991, Vol 202, Num 4, pp 217-224, issn 0030-3755Article

Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastomaCALAFIORE, L; AMOROSO, L; GARAVENTA, A et al.Annals of oncology. 2013, Vol 24, Num 5, pp 1406-1413, issn 0923-7534, 8 p.Article

Is the control of disease progression within our grasp ? Review of the GRISAR studyFERRACCIOLI, G. F; DELLA CASA-ALBERIGHI, O; MARUBINI, E et al.British journal of rheumatology. 1996, Vol 35, pp 8-13, issn 0263-7103, SUP2Conference Paper

Clinical trials in rheumatoid arthritis : methodological suggestions for assessing radiographs arising from the GRISAR^* studyFERRARA, R; PRIOLO, F; CAMMISA, M et al.Annals of the rheumatic diseases. 1997, Vol 56, Num 10, pp 608-612, issn 0003-4967Article

Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin APASERO, G; PRIOLO, F; TIRRI, G et al.Arthritis and rheumatism. 1996, Vol 39, Num 6, pp 1006-1015, issn 0004-3591Article

The rationale of pharmacoeconomic analysis in rheumatologic indicationsTURCHETTI, G; SCALONE, L; DELLA CASA ALBERIGHI, O et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S64-S71, SUP73Article

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndromePONTICELLI, C; RIZZONI, G; PASQUALI, S et al.Kidney international. 1993, Vol 43, Num 6, pp 1377-1384, issn 0085-2538Article

Cyclosporin versus cyclophosphamide for patients with steroid- dependent and frequently relapsing idiopathic nephrotic syndrome : a multicentre randomized controlled trialPONTICELLI, C; EDEFONTI, A; BETTINELLI, A et al.Nephrology, dialysis, transplantation (Print). 1993, Vol 8, Num 12, pp 1326-1332, issn 0931-0509Conference Paper